Cargando…
ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway
Atrial fibrillation (AF) is the more significant portion of arrhythmia in clinical practice, with inflammation and fibrosis as its central pathological mechanisms. This study aimed to investigate angiopoietin-like 4 (ANGPTL4) effects on angiotensin II- (Ang II-) induced AF and its related pathophysi...
Autores principales: | Zhu, Xi, Zhang, Xiaogang, Cong, Xinpeng, Zhu, Luoning, Ning, Zhongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371667/ https://www.ncbi.nlm.nih.gov/pubmed/34422410 http://dx.doi.org/10.1155/2021/9935310 |
Ejemplares similares
-
Inhibition of FABP4 attenuates cardiac fibrosis through inhibition of NLRP3 inflammasome activation
por: Zhu, Xi, et al.
Publicado: (2022) -
ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ
por: Zhu, Xi, et al.
Publicado: (2023) -
Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation
por: Cao, Wei, et al.
Publicado: (2021) -
Inhibition of UCHL1 by LDN-57444 attenuates Ang II–Induced atrial fibrillation in mice
por: Bi, Hai-Lian, et al.
Publicado: (2019) -
Percutaneous Retrieval of Left Atrial Appendage Closure Devices in Patients With Atrial Fibrillation: A Case Report
por: Wang, Saihua, et al.
Publicado: (2022)